
Browse
related articles
High oil prices boost oil stocks
- Tuesday, April 12 - 2005 at 08:23
High oil price levels still benefited oil stocks with the healthcare sector being another winner in the aftermath of massive restructurings and a better outlook for Pfizer. Most investors were awaiting the start of the new earnings season that really kicks off next week.
Economics
This week we expect US industrial production growth in March to accelerate while growth in underlying retail sales remains robust. The trade deficit for February is expected to deteriorate slightly.
In Europe we expect French industrial production growth for February to fall back after recent strong rates. French consumer price inflation should remain stable for March.
On the political front the meeting of European finance ministers will focus on the fiscal situation across countries. In Japan we expect consumer confidence in March to remain steady.
Foreign exchange
Euro/Dollar: The euro is close to a test of its long-term support line at 1.2730. The fact that this level corresponds with the previous low recorded in February makes this an important support level.
Euro/Yen: The dollar broke out of its long term downtrend channel suggesting further gains with 110.00 and 111.50 as next resistance levels.
Fixed Income
Globally yields were quite stable over the past week. A slight rebound was seen at the end of the week after some Federal reserve members commented on inflation pressures or the need to 'lift rates more vigorously'. In Europe, the ECB left rates unchanged as largely expected.
Even though there are no major inflation pressures at the moment, medium-term risks remain due to the high growth rates of monetary aggregates. German industrial production fell in February reinforcing the worries about weak growth in Europe.
Equities
It was quiet on the stock markets with no major oil price movements or company news. On both sides of the ocean, indices went up slightly. In the US, all indices were remarkably higher four days in a row, albeit at limited pace.
High oil price levels still benefited oil stocks with the healthcare sector being another winner in the aftermath of massive restructurings and a better outlook for Pfizer. Most investors were awaiting the start of the new earnings season that really kicks off next week.

Browse
related articles
Today's most read articles:
Internaxx
Tuesday, April 12 - 2005 at 08:23 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited
without the prior written consent of AME Info FZ LLC / Emap Limited.
This article was updated on Sat May 26 2007.
Internaxx Disclaimer:
This content in this section was prepared by the research department of MeesPierson and Fortis Global Markets. This document does not constitute financial advice. If you require such advice, you should seek appropriate professional advice.
Internaxx accepts no responsibility for the content of in this section.
Disclaimer:
The information comprised in this section is not, nor is it held out to be,
a solicitation of any person to take any form of investment decision. The
content of the AMEinfo.com Web site does not constitute advice or a
recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making
(or refraining from making) any decision relating to investments or any
other matter. You should consult your own independent financial adviser and
obtain professional advice before exercising any investment decisions or
choices based on information featured in this AMEinfo.com Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any
opinions, suggestions, recommendations or comments made by any of the
contributors to the various columns on the AMEinfo.com Web site nor do
opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever,
including, without limitation, direct, special, indirect, consequential, or
incidental damages, or damages for lost profits, loss of revenue, or loss
of use, arising out of or related to the AMEinfo.com Web site or the
information contained in it, whether such damages arise in contract,
negligence, tort, under statute, in equity, at law or otherwise.